Cargando…
Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes
Type 2 diabetes mellitus (T2DM) is mainly characterized by insulin resistance (IR) and impaired insulin secretion. The chronic inflammatory process contributed to IR and could also hamper pancreatic β cell function. However, currently applied treatment cannot reverse β cell damage or alleviate infla...
Autores principales: | Qi, Yicheng, Ma, Jing, Li, Shengxian, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712852/ https://www.ncbi.nlm.nih.gov/pubmed/31455405 http://dx.doi.org/10.1186/s13287-019-1362-2 |
Ejemplares similares
-
Adipose-derived mesenchymal stem cells from obese mice prevent body weight gain and hyperglycemia
por: Qi, Yicheng, et al.
Publicado: (2021) -
Antioxidative Capacity of Liver- and Adipose-Derived Mesenchymal Stem Cell-Conditioned Media and Their Applicability in Treatment of Type 2 Diabetic Rats
por: Elshemy, Mohamed M., et al.
Publicado: (2021) -
Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats
por: Yu, Songyan, et al.
Publicado: (2019) -
Adipose-derived Mesenchymal Stem Cells Therapy as a new Treatment Option for Diabetes Mellitus
por: Mikłosz, Agnieszka, et al.
Publicado: (2023) -
Topical applications of allogeneic adipose-derived mesenchymal stem cells ameliorate the canine keratoconjunctivitis sicca
por: Wei, Li-Ning, et al.
Publicado: (2022)